Will Testing for Tumor Mutational Burden Bring the Same Challenges as Testing for PD-L1?

被引：0
|
作者：
Gupta V. [1 ]
Ramirez M.C. [1 ]
Schauser L. [1 ]
机构：
[1] QIAGEN, India
来源：
Genetic Engineering and Biotechnology News | 2019年 / 39卷 / 06期
关键词：
3;
D O I：
10.1089/gen.39.06.19
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：56 / 57
页数：1
相关论文
共 50 条
  • [1] Tumor Mutational Burden and PD-L1 Expression in Hematologic Malignancies
    Thomas, Sean D.
    Jeong, Ah-Reum
    Sakowski, Patrick J.
    Sokol, Ethan S.
    Kurzrock, Razelle
    Goodman, Aaron M.
    BLOOD, 2020, 136
  • [2] Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
    Peters, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S74 - S74
  • [3] Cost-effectiveness of PD-L1 testing and tumor mutational burden testing of immune checkpoint inhibitors for non-small cell lung cancer.
    Li, Wenqian
    Li, Lingyu
    Chen, Naifei
    Cui, Jiuwei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
    Yarchoan, Mark
    Albacker, Lee A.
    Hopkins, Alexander C.
    Montesion, Meagan
    Murugesan, Karthikeyan
    Vithayathil, Teena T.
    Zaidi, Neeha
    Azad, Nilofer S.
    Laheru, Daniel A.
    Frampton, Garrett M.
    Jaffee, Elizabeth M.
    JCI INSIGHT, 2019, 4 (06)
  • [5] PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development
    Hansen, Aaron R.
    Siu, Lillian L.
    JAMA ONCOLOGY, 2016, 2 (01) : 15 - 16
  • [6] Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy
    Hu, Weixian
    THORACIC CANCER, 2020, 11 (01) : 3 - 5
  • [7] Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer.
    George, Thomas J.
    Frampton, Garrett Michael
    Sun, James
    Gowen, Kyle
    Kennedy, Mark
    Greenbowe, Joel R.
    Schrock, Alexa Betzig
    Ali, Siraj Mahamed
    Klempner, Samuel Jacob
    Flezel, Aram F.
    Ross, Jeffrey S.
    Stephens, Phil
    Miller, Vincent A.
    Fabrizio, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] PD-L1 testing in breast cancer
    Horii, Rie
    ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
  • [9] PD-L1 testing in gastric cancer
    Ushiku, Tetsuo
    ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
  • [10] PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation
    Cree, Ian A.
    Booton, Richard
    Cane, Paul
    Gosney, John
    Ibrahim, Merdol
    Kerr, Keith
    Lal, Rohit
    Lewanski, Conrad
    Navani, Neal
    Nicholson, Andrew G.
    Nicolson, Marianne
    Summers, Yvonne
    HISTOPATHOLOGY, 2016, 69 (02) : 177 - 186
12345